The paradox of decreasing prices and increasing costs for diagnostic tests, imaging, and drugs in Japan

Naoki Ikegami, Shunya Ikeda

研究成果: Article

2 引用 (Scopus)

抄録

Analysis of the 1987-91 national outpatient claims data shows that the percentage of patients undergoing sophisticated diagnostic tests tended to increase and was greater if the hospital was larger, in the public sector, or affiliated with an university. For imaging, the percentage that had CAT scans performed increased, while the percentage undergoing x-rays using contrast medium and other tomography decreased. However, for drugs, newer and more expensive ones tended to be preferred irrespective of the providers' characteristics. Although costs arising from the shift to more expensive and sophisticated technologies have been largely contained by reducing their prices in the fee schedule, this cost-containment strategy faces structural problems. We advocate the establishment of an infrastructure that offers incentives for providers to conduct technology assessment and to use the results.

元の言語English
ページ(範囲)99-110
ページ数12
ジャーナルInternational Journal of Technology Assessment in Health Care
13
発行部数1
出版物ステータスPublished - 1997

Fingerprint

Fee Schedules
Biomedical Technology Assessment
Cost Control
Public Sector
Diagnostic Imaging
Routine Diagnostic Tests
Contrast Media
Motivation
Japan
Outpatients
Tomography
X-Rays
Technology
Costs and Cost Analysis
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Health Informatics
  • Health Information Management
  • Nursing(all)

これを引用

@article{98bff7f48b4f4d93927d9a7415bf0628,
title = "The paradox of decreasing prices and increasing costs for diagnostic tests, imaging, and drugs in Japan",
abstract = "Analysis of the 1987-91 national outpatient claims data shows that the percentage of patients undergoing sophisticated diagnostic tests tended to increase and was greater if the hospital was larger, in the public sector, or affiliated with an university. For imaging, the percentage that had CAT scans performed increased, while the percentage undergoing x-rays using contrast medium and other tomography decreased. However, for drugs, newer and more expensive ones tended to be preferred irrespective of the providers' characteristics. Although costs arising from the shift to more expensive and sophisticated technologies have been largely contained by reducing their prices in the fee schedule, this cost-containment strategy faces structural problems. We advocate the establishment of an infrastructure that offers incentives for providers to conduct technology assessment and to use the results.",
author = "Naoki Ikegami and Shunya Ikeda",
year = "1997",
language = "English",
volume = "13",
pages = "99--110",
journal = "International Journal of Technology Assessment in Health Care",
issn = "0266-4623",
publisher = "Cambridge University Press",
number = "1",

}

TY - JOUR

T1 - The paradox of decreasing prices and increasing costs for diagnostic tests, imaging, and drugs in Japan

AU - Ikegami, Naoki

AU - Ikeda, Shunya

PY - 1997

Y1 - 1997

N2 - Analysis of the 1987-91 national outpatient claims data shows that the percentage of patients undergoing sophisticated diagnostic tests tended to increase and was greater if the hospital was larger, in the public sector, or affiliated with an university. For imaging, the percentage that had CAT scans performed increased, while the percentage undergoing x-rays using contrast medium and other tomography decreased. However, for drugs, newer and more expensive ones tended to be preferred irrespective of the providers' characteristics. Although costs arising from the shift to more expensive and sophisticated technologies have been largely contained by reducing their prices in the fee schedule, this cost-containment strategy faces structural problems. We advocate the establishment of an infrastructure that offers incentives for providers to conduct technology assessment and to use the results.

AB - Analysis of the 1987-91 national outpatient claims data shows that the percentage of patients undergoing sophisticated diagnostic tests tended to increase and was greater if the hospital was larger, in the public sector, or affiliated with an university. For imaging, the percentage that had CAT scans performed increased, while the percentage undergoing x-rays using contrast medium and other tomography decreased. However, for drugs, newer and more expensive ones tended to be preferred irrespective of the providers' characteristics. Although costs arising from the shift to more expensive and sophisticated technologies have been largely contained by reducing their prices in the fee schedule, this cost-containment strategy faces structural problems. We advocate the establishment of an infrastructure that offers incentives for providers to conduct technology assessment and to use the results.

UR - http://www.scopus.com/inward/record.url?scp=0030992433&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030992433&partnerID=8YFLogxK

M3 - Article

C2 - 9119627

AN - SCOPUS:0030992433

VL - 13

SP - 99

EP - 110

JO - International Journal of Technology Assessment in Health Care

JF - International Journal of Technology Assessment in Health Care

SN - 0266-4623

IS - 1

ER -